| Product NDC: | 0615-6558 | 
| Proprietary Name: | Sertraline | 
| Non Proprietary Name: | Sertraline Hydrochloride | 
| Active Ingredient(s): | 25 mg/1 & nbsp; Sertraline Hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0615-6558 | 
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077397 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20071218 | 
| Package NDC: | 0615-6558-39 | 
| Package Description: | 30 TABLET in 1 BLISTER PACK (0615-6558-39) | 
| NDC Code | 0615-6558-39 | 
| Proprietary Name | Sertraline | 
| Package Description | 30 TABLET in 1 BLISTER PACK (0615-6558-39) | 
| Product NDC | 0615-6558 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Sertraline Hydrochloride | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20071218 | 
| Marketing Category Name | ANDA | 
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs | 
| Substance Name | SERTRALINE HYDROCHLORIDE | 
| Strength Number | 25 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |